2018 Gastrointestinal (GI) Tumor Board (Occurs Weekly, Every Tuesday)

2018 Gastrointestinal (GI) Tumor Board (Occurs Weekly, Every Tuesday) Banner


Date & Location
Occurs weekly every Tuesday starting on 1/2/2018 at 7:00 AM, FHCI Orlando - Conference Room, Suite 182, Orlando, FL

Target Audience
Colon and Rectal, Family Medicine, Fellow / Resident, Gastroenterology, Hematology/Oncology, Internal Medicine, Oncology, Pathology, Radiation Oncology, Radiology, Student, Surgery (All)

Overview
Multidisciplinary Team of Physicians discuss the latest staging, NCCN/ Gastrointestinal (GI) Guideline and study materials as applicable for each patient presented. The Physicians are fully engaged in finding the best treatment available for favorable outcomes.

Objectives

At the end of this course, participants should be able to:
  1. Utilize a Multidisciplinary, Case-Based Approach to discuss recent treatment guidelines to improve care for various cancer patients.
  2. Evaluate current clinical trials underway so that appropriate cancer patients may be considered for enrollment in those tirals.
  3. Share lessons learned in treatment of difficult cases in ordcer to provide alternative therapies for enrollment in those trials.
  4. Review site specific NCCN/ Gastroninestinal (GI) Specific Guidelines as appropriate per case.

Registration

COST: Complimentary

Occurs Every Tuesday of each Month - 7:00 AM - 8:00 AM



Accreditation

Florida Hospital is accredited by the Florida Medical Association (FMA) to provide continuing medical education for physicians. Florida Hospital designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.

Physicians should only claim the credit commensurate with the extent of their participation in the activity.


Location:

Florida Hospital Cancer Institute
Conference Room, Suite 182
2501 N. Orange Ave., Orlando, FL 32804

Disclosures:

Florida Hospital's CPD Committee members have no financial relationships with any proprietary entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.

The following speakers have financial relationships with the companies listed:

  • Dr. Matthew Albert - Stryker
  • Dr. Juan Pablo Arnoletti - Pfizer, Inc.
  • Dr. Raul Castillo - GlaxoSmithKline, Merck and Company, Inc., ABBvi, and Pfizer, Inc.
  • Dr. Sebastian De La Fuente - Johnson and Johnson, and TransEnterix.
  • Dr. Teresa H.debeche-Adams - Applied Medical, and Trans Enterix.
  • Dr. Robert H. Hawes - Olympus, Boston Scientific Corporation, and Medtronic.
  • Dr. John Monson - Johnson and Johnson, and Medtronic, Inc.
  • Dr. George Nassif Jr. - Applied Medical, and Mallincrodkt.
  • Dr. Ravi Shridhar - Biocompatilbes.
  • Dr. Mark Soliman - Intutive Surgical.

The following speakers have no financial relationships with any proprietary entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients:

  • Dr. Osama 'Sam' Atallah
  • Dr. Francisco Couto
  • Dr. Jeremy Marcus Drake
  • Dr. Arman Erkan
  • Dr. Nicholas Feranec
  • Dr. Shani Fruchter
  • Dr. Sarah George
  • Dr. Ashkan Ghaneie
  • Dr. Antonio Gonzalez
  • Dr. Justin Kelly
  • Dr. Bruce Orkin
  • Dr. Jie Ouyang
  • Dr. Peter Pernicone
  • Dr. Ahmed Zakari

Certificate:

Participants must text the lecture code to receive the evaluation; the evaluation must be completed to receive both the certificate and credit with CE Broker.